Literature DB >> 27914635

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease.

Jan Müller1, Pinar Bambul Heck2, Peter Ewert2, Alfred Hager2.   

Abstract

BACKGROUND: Patients with congenital heart disease and native or palliated conditions are at risk to develop pulmonary hypertension (PH) in later life. Screening for PH is currently performed by regular echocardiographic follow-up, which appears to be difficult in several congenital conditions. This study evaluated the screening for PH in congenital heart disease by cardiopulmonary exercise testing (CPET).
METHODS: We analyzed our database including all patients with congenital heart disease referred for CPET in our institution from June 2001 to September 2013 and identified 683 patients who had an accompanied heart catheterization less than 6 month after CPET. Those 130 patients with proven PH were compared with the other 563 patients with congenital heart disease but without PH.
RESULTS: Peak oxygen uptake was the most discriminative variable, showing two thresholds at 16.3 mL/min per kg and 25.2 mL/min per kg. The highest specificity of 95% for PH was found in patients with a peak oxygen uptake of 16.3 mL/min per kg or less and a breathing reserve of 37.4% or less. In patients with a peak oxygen uptake exceeding 16.3 mL/min per kg, there was a high specificity of 86.3% but a low sensitivity of 53.1%. With 25.2 mL/min per kg as the threshold, the sensitivity for PH was only 10.0%.
CONCLUSIONS: Detection of PH in patients with congenital heart disease by CPET is difficult because of many falsely positive tests. However, a peak oxygen uptake higher than 25.2 mL/min per kg makes the diagnosis of PH unlikely.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27914635     DOI: 10.1016/j.athoracsur.2016.09.038

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  A Novel MEF2C Loss-of-Function Mutation Associated with Congenital Double Outlet Right Ventricle.

Authors:  Cai-Xia Lu; Wei Wang; Qian Wang; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2018-02-21       Impact factor: 1.655

2.  Non-invasive Hemodynamic CMR Parameters Predicting Maximal Exercise Capacity in 54 Patients with Ebstein's Anomaly.

Authors:  Christian Meierhofer; Andreas Kühn; Jan Müller; Nerejda Shehu; Alfred Hager; Stefan Martinoff; Heiko Stern; Peter Ewert; Manfred Vogt
Journal:  Pediatr Cardiol       Date:  2019-02-06       Impact factor: 1.655

3.  Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I.

Authors:  Catherine G Billings; Robert Lewis; Iain J Armstrong; Judith A Hurdman; Ian A Smith; Matthew Austin; Charlie A Elliot; Athanasios Charalampopoulos; Ian Sabroe; Allan Lawrie; A A Roger Thompson; Robin Condliffe; David G Kiely
Journal:  Front Med (Lausanne)       Date:  2018-06-21

4.  Hybrid procedure for treating adult congenital heart disease with valvular heart disease in two patients.

Authors:  Chun-Sheng Li; Zhong Lu; Xiao-Rong Song; Zhong-Ya Yan
Journal:  J Cardiothorac Surg       Date:  2019-10-23       Impact factor: 1.637

5.  MEF2C loss-of-function mutation contributes to congenital heart defects.

Authors:  Xiao-Hui Qiao; Fei Wang; Xian-Ling Zhang; Ri-Tai Huang; Song Xue; Juan Wang; Xing-Biao Qiu; Xing-Yuan Liu; Yi-Qing Yang
Journal:  Int J Med Sci       Date:  2017-09-08       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.